Order Article Reprints

Menendez CA, Mohamed A, Perez-Lemus GR, Weiss AM, Rawe BW, Liu G, Crolais AE, Kenna E, Byléhn F, Alvarado W, et al. Development of Masitinib Derivatives with Enhanced M^pro Ligand Efficiency and Reduced Cytotoxicity. Molecules. 2023; 28(18):6643. https://doi.org/10.3390/molecules28186643

Menendez, Cintia A., Adil Mohamed, Gustavo R. Perez-Lemus, Adam M. Weiss, Benjamin W. Rawe, Guancen Liu, Alex E. Crolais, Emma Kenna, Fabian Byléhn, Walter Alvarado, and et al. 2023. "Development of Masitinib Derivatives with Enhanced M^pro Ligand Efficiency and Reduced Cytotoxicity" Molecules 28, no. 18: 6643. https://doi.org/10.3390/molecules28186643

Menendez, C. A., Mohamed, A., Perez-Lemus, G. R., Weiss, A. M., Rawe, B. W., Liu, G., Crolais, A. E., Kenna, E., Byléhn, F., Alvarado, W., Mendels, D., Rowan, S. J., Tay, S., & de Pablo, J. J. (2023). Development of Masitinib Derivatives with Enhanced M^pro Ligand Efficiency and Reduced Cytotoxicity. Molecules, 28(18), 6643. https://doi.org/10.3390/molecules28186643